During the past decade, iBiomed Research Unit conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "iBiomed Research Unit" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "iBiomed Research Unit" are "Triple Negative Breast Cancer" (2 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Gastric Cancer" (1 trials), "Gastroesophageal Junction Adenocarcinoma" (1 trials) and "Myasthenia Gravis" (1 trials). Many other conditions were trialed in "iBiomed Research Unit" in a lesser frequency.

Most popular intervention types in "iBiomed Research Unit" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials) and "Sacituzumab Govitecan-hziy" (2 trials). Other intervention names were less common.

The vast majority of trials in "iBiomed Research Unit" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "iBiomed Research Unit". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in iBiomed Research Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in iBiomed Research Unit, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".